Showing posts with label BAT. Show all posts
Showing posts with label BAT. Show all posts

Tuesday, October 22, 2013

Fat Burners Don't Work in the Obese!? BAT Activity Almost Zero, Even after the Ingestion of ~290mg Ephedrine!

Do thermogenic fat burners only work if you already look like this? I mean, what would be the sure, then and why did the ECA stack work for overweight people, as well?
I don't know if you have ever thought about the problems mostly involuntarily obese individuals are facing in their everyday lives!? Even if you discard the constant bullying and the subliminal messages they receive from their peers, not fitting into a regular seat in an airplane certainly is more than just an embarrassment. Now what would you say, if I told you that they are discriminated against even, when they shop at their local GNC, or whichever other supplement vendor they may be using? And I am not talking about the lean guys and girls on the labels of the supplements, here! No, I am referring to a discrimination that takes place on a more fundamental level and it happens right in front of the shelf with every overweight person's favorite supplements: The so-called fat burners!

Ok, now that I got everyone's attention, I guess its about time to break the news: Fat burners don't burn fat!

If this does not happen to be your first visit, here, at the SuppVersity you may now be asking yourself how an (unfortunately still not so) common wisdom like this could make it into the news... right? Well, the answer is simple: In addition to the fact that the active fat burning effects of almost all thermogenics are negligible, so that they can - if anything - support your nutritional weight loss efforts by making it easier for you to stick to your diet and training regimen, a recent study by Carey et al. suggests that the minimal effects they do actually have diminish with each pound of superfluous body fat you are carrying around (Carey. 2013).

"Hold on! 2.5mg/kg ephedrine? That's 170mg and 287.5mg ephedrine. That's madness!" Usually I would say "yeah, you are right", but based on previous studies (Nedergaard . 2011), Carey et al. knew that 1.0mg/kg did not elicit any BAT activity, despite significant physiological adrenergic responses (blood pressure and heart rate; cf. Astrup. 1985a,b). I still don't have to tell you not to "try that at home" - and this is more than just a "parenteral advisory" ;-)
In a randomized, double-blinded, crossover trial, the Australian researchers administered 2.5 mg/kg of ephedrine to nine lean (BMI 22±1 kg/m²) and nine obese (BMI 36±1 kg/m²) young men and measured the thermogenic response of their "fat burning" brown adipose tissue (note: BAT burns glucose as well and the activity of the latter is usually measured by [18F]fluorodeoxyglucose, which can be detected via PET-CT imaging).
Figure 1: PET-CT scan of lean (left) and obese (right) individual (Carey. 2013)
As the images in figure 1 clearly shows the actual BAT activity (located in the neck, where humans carry almost all their BAT; cf. Zingaretti. 2009), which has long been hailed as the underlying reason of the real-world effects the administration of ephedrine HCL, ephedra or mua huang, was far from earth-shaking and by no means comparable to what you would expect based on the almost legendary status of ephedrine as "the most potent thermogenic" that ever hit the market.

Keep in mind: There are also inter-individual differences in the amount of BAT people have. Still the differences between lean and obese were so pronounced that you can hardly argue that the results of the study were mere coincidence.

What is even more striking than the overall magnitude of BAT activity the scientists observed is however that the latterw was more or less completely absent in the obese individuals -- and that despite the fact that I am honestly wondering none of them collapsed after ingesting his 287mg of ephedrine (remember the dosages were scaled according to body weight!). When you think about it, the scientists subsequent conclusion that they have...
"[...] demonstrated for the first time that BAT can be activated in the majority of lean, but not in obese humans with a single dose of ephedrine" (Carey. 2013)
could in fact have far reaching consequences that are not simply restricted to the use of respective dietary supplements, but extend into the realms of the development of future anti-obesity drugs and the use and usefulness of "alternative" obesity "treatments", such as cold exposure, as well.The latter for example may be a more potent activator of BAT activity than ephedrine, but it's falling short, when it comes to the centrally mediated effects, of which it is now becoming increasingly clear that they and not the insignificant BAT activity must be responsible for the indisputable real-world weight loss effects, both, lean and overweight individuals, have seen in the past, when they consumed much lower doses of ephedrine, than the subjects in the study at hand.
Figure 2: BAT activity, nor-adrenaline response, changes in systolic (SBP) and diastolic (DBP) blood pressure in response to 2.5mg/kg body weight ephedrine in lean and obese subjects (data based on Carey. 2013)
If we also take into account that ephedrine is probably still one the most potent inducers of BAT activity among the (formerly) OTC thermogenics and most currently available (and recently banned) ingredients are nothing but central nervous system stimulants, the scientists' remark that their "data highlight[s] the poor responsiveness of BAT to systemic adrenergic stimulation compared with that of the cardiovascular system", should actually make it pretty obvious why so many of the purported (and in some cases even factual) thermogenics don't deliver the "fat burning" results their consumers are expecting: At the moment they start to work, the cardiovascular side-effects are already in the "danger zone", so that anything but a negligible increase in thermogeneisis is rare in the lean and - as the study at hand would suggest - probably totally absent in the average obese diet pill junkie.

Thermogenics won't work for you, but you can work with them... not infinitely, though! 

You can't light the candle from both sides and still expect it to last forever. Stims and meditation are like Jing and Jang, and you got to master them both (read more about how meditation can increase telomere length by 50%).
That many of these products do still work and that they do so even in the obese, as long as they are willing to accept that these products are adjuvants to and not replacements for a sound nutrition and exercise regimen, is thus probably more of a result of their ability to keep you training and dieting longer and harder, than due to any real "thermogenenic" effect. That said, I guess, I don't have to tell you that you cannot light the candle from both sides and expect to last it forever, do I?

Oh, I see, ... I would first have to to tell you what that's supposed to mean, right?! Well, basically it means that unless you want to make the acquaintance of "adrenal fatigue", "central fatigue syndrome" and the "athlete's triad", you better restrict the use of respective products to short time periods of max. 4-6 weeks and make sure not to (ab-)use them to simply ignore the physical necessity of rest and recovery! Believe it, or not, both of them are equally, if not more important, when you are trying to get ripped, as they are, when you are trying to get buffed.

References:
  • Astrup A, Lundsgaard C, Madsen J, Christensen NJ. En-hanced thermogenic responsiveness during chronic ephedrine treatment in man. Am J Clin Nutr. 1985a; 42:83–94
  • Astrup A, Bulow J, Madsen J, Christensen NJ. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. Am J Physiol. 1985b; 248:E507–E515
  • Carey AL, Formosa MF, Van Every B, Bertovic D, Eikelis N, Lambert GW, Kalff V, Duffy SJ, Cherk MH, Kingwell BA. Ephedrine activates brown adipose tissue in lean but not obese humans. Diabetologia. 2013 Oct 13.
  • Nedergaard J, Bengtsson T, Cannon B. New powers of brown fat: fighting the metabolic syndrome. Cell Metab. 2011 Mar 2;13(3):238-40.
  • Vosselman MJ, van der Lans AA, Brans B, Wierts R, van Baak MA, Schrauwen P, Lichtenbelt WD. Systemic β-Adrenergic Stimulation of Thermogenesis Is Not Accompanied by Brown Adipose Tissue Activity in Humans. Diabetes. 2013 Aug 7.
  • Zingaretti MC, Crosta F, Vitali A et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J, 2009; 23:3113–3120.

Monday, January 28, 2013

How Working Out Changes the Morphology of Your Body Fat and Why This Explains that Intensity and Explosiveness Hold the Key to Getting and Staying Lean, Fit and Healthy

Can the guy on the right run away from the bloated macrophage coated fat cells on the left? Today's first post in the SuppVersity Exercise Science Week does hold the answer to this existential question.
Those of you who don't just read, but also think about the headlines of these posts will probably already have theorized about the remote possibility that I could have changed my mind and discarded the original plan to do an "exercise quickie" early this week (see SuppVersity post from Saturday). Now, before you are getting mad at me, let me give you the (as I would say good) reason for doing that: Some, if not almost all of the exercise related studies, I have piled up here are actually too interesting to end up as part of a mash-up. That's particularly true in view of the fact that my time budget during the week does not allow me to discuss them in appropriate detail. So, even if wanted to end up writing >10,000 word posts, this would only work on 48h days ;-)

The solution I came up with is easy and in my humble opinion actually quite cool: The world's first SuppVersity Exercise Science Week! In the course of the next days, I will serve you one or two of the latest studies from the realms of exercise science per day - with the rest (if there is one) being "mashed up" in the Short News on Saturday. Cool? No? Well, bad luck, then ;-)

We will kick off the week with the modulatory effect of exercise on adipose tissue

We all know that exercise is a good way to support and control diet induced weight loss. Specifically for those of us who are already on the lean(er) side of a "divide", where obese is soon going to be the new normal (see "Obese is Going About to Become the New Normal"), it's probably even obligatory, if it's not being skinny fat that's our diet goal. That being said, a recent review of Izawa et al. provides a couple of intriguing insights and links between physical activity and the structural changes our white adipose tissue is undergoing (Izawa . 2013). In this first post of the SuppVersity Exercise Science Week I am going to summarize and expand on some of these points and point towards the implications these more or less recent, in parts pretty geeky and abstract findings have on the way we could, should, or might train:
  • Training can increase lypolysis: Compared to subcutaneous fat (SAT), visceral fat (VAT) has a higher lipid turnover. Interestingly, the same high lypolytic rates which render people with high VAT so vulnerable to high levels of blood fats, are also responsible for the comparable ease with which you can shake those unhealthy VAT depots melt away, when you're working out and/or dieting. The fat around the organs is not just the easiest to store, it's also the easiest to access and liberate (Ross. 2000). That this is not a location-specific characteristic, has already been proven. What does yet still have to be elucidated, is when and due to which complex mechanisms the genetic differences between the subcutaneous and visceral fat cells are getting programmed and whether there may be a way to reverse them.
  • Training will modulate the growth environment: The maturation of stem cells into SAT, VAT, or BAT (brown adipose tissue) cells appears to be highly dependent the specific milieu in which they are in. The latter, in turn, is characterized by the presence of  various growth factors. The best known and allegedly most important ones belong to the transforming growth  factor (TGF) family. It is their presence that will control whether a stem cell turns into a "brown" = metabollically active fat cell with thermogenic abilities or a regular white one (SAT or VAT). While BMP2- and BMP-4 are responsible for the formation of white adipocytes, BMP-7 drives brown fat cell development. Together with FGF21 another of those growth factors, these proteins determine the fate of pre-adipocytes. Unfortunately, the research on the different ways by which exercise controls these factors is yet still in its infancy. We will take a closer look at what we know already in the next paragraph.
  • As you know from the "CLA Destroys Body Fat" post, PPAR-γ downregulation is also the main pathway by which conjugated linolic acid strips mice of almost all their body fat (read more). The exercise induced upregulation of the so-called hypoxia-inducible factor (HIF-1α) appears to do the exact same thing: Suppress PPAR-γ and thus hit the off switch on body fat storage.
    Training reduces WAT size and number: According to a 2004 review of the literature it appears as if exercise training (aerobic) specifically in early life reduces the number and size of WAT in rodent (Stallknecht. 2004). These results have been confirmed in a 5-week study designed that was conducted to elicit the underlying molecular mechanisms only recently (Sakurai. 2010); and the results of the Sakurai study suggest that it is one of our old acquaintances that is to "blame": The peroxisome proliferator-activated receptor-γ (PPAR-γ), a central regulator of adipogenesis! It's inhibition by physical activity is what does the trick. Now, as a diligent student of the SuppVersity you will certainly remember that this is also the main pathway by which CLA, rhein (from rhubarb) and other weight loss adjuvants work their "magic" - a blockade of the PPAR-γ receptor is like hitting the "off switch" on the body fat storage control panel. And who is it who hits that switch? Well, according to the current research it appears that this is the prerogative of the hypoxia-inducible factor (HIF-1α) which is in turn controlled by exercise induced WNT and AMPK signaling.
  • Training improves angiogenesis in WAT: While you hear about angiogenesis, i.e. the physiological process through which new blood vessels form from pre-existing vessels, oftentimes in the context of various endothelial pathologies, its induction within the white adipose tissue is actually highly desirable. Scientists have long been speculating that the insufficient wiring of the adipose organ with blood vessels and the subsequent hypoxia are at least partly to blame for the constant inflammation in the ever-expanding fat depots of the obese (Ye. 2009). Since HIF-1α (see previous paragraph) also promotes the expression of vascular endothelial growth factors and their receptors (VEGFRs / VEGFs), its downstream activation by preferably intense physical activity should improve the endothelial wiring of the fat tissue and thus help sooth the chronic inflammation, that's at the heart of many, if not all of the key-features of the "metabolic syndrome".
  • Training increases the adipocyte size depended release of adiponectin: In the past couple of months, the adipokine adiponectin turned out to do most of the good stuff (esp. improvements in glucose and fatty acid metabolism), of which scientists previously thought it was the prerogative of leptin. It is therefore important that exercise increases the rate at which a given increase in adipocyte size (obviously in response to fat storage) will increase the release of adiponectin (Miyazaki. 2010). If we use the classic notion of the adipokine as a signal the fat cells use to tell the brain and the rest of the body how much fat remains to fuel its energetic demands, you could say: Working out allows your body to see how much fat you actually got. The physiological consequences of this revelation are increases in lypolysis and fatty oxidation, as well as overall metabolic benefits.
So far for the stuff that will make you look smart, when you parrot it in front of your gymbros. In order to not just look smart, but also be smart -- and in this case train smart -- you will yet also have to know the implications of these revelations and this is exactly what the rest of this article is going to deal with:
  • Making HIIT a Hit! learn how in the SuppVersity  Special (read more) and use it to get lean & healthy and, more importantly, stay lean and healthy!
    HIF-1α <> PPAR-γ <> adipocyte crosstalk - an(-other) argument for high intensity exercise: Since the HIF-1α response to a given training stimulus decreases once the body has adapted to the stressor by increasing its exercise capacity (Lundby. 2005). The crosstalk between HIF-1α, PPAR-γ, and your fat cells provide another reason to work out in the higher range of the VO2max continuum and to never neglect the imperative of constant progression (even if it's only a progression of 0.1km/h during your sprints on the treadmill - adaptation means stagnation, if you don't raise the bar appropriately)
  • Wnt10B response to stretching - an argument for heavy eccentrics and/or statics to revamp your body (less fat, more muscle!): The findings of Akimoto et al. point towards the existence of another rather strength-training specific contributer to the fat loss and leanness promoting effects of exercise - the stretch-induced activation of the wingless-type (WNT) MMV integration site family member WNT10b, the quasi cousin of an upstream mediator of HIF-1α (Akimoto. 2005). The activation of the WTNs does actually get down to the root of the trouble and will not just inhibit the formation of new fat cells from pre-adipocytes, it will also divert the mesenchymal and not yet specialized stem cells to turn into osteroblasts (bone) or myoblasts (muscle). In fact, research has shown that WNT signaling is a major contributer to both the recruitment of new muscle progenitor cells from the aforementioned pool of yet unspecific stem cells and skeletal muscle hypertrophy (Polesskaya. 2005; Armstrong. 2005).
  • You will also benefit from integrating plyometrics into your existing routine - build the Jack of All Traits Workout
    The greater WNT response to power vs. strength training points towards the superiority of a plyometrics to get and stay lea: In view of the results of Leal et al., who report a 3x greater WNT gene response to power compared to strength training in their 2011 paper on the effect of different resistance-training regimens on the WNT-signaling pathway, plyometrics, which have way more in common with the power training protocol in the Leal study (40% lighter weights; faster, explosive contractions) than whatever powerlifting routine you may have been thinking of, should be a superior means to stay lean (Leal. 2011)
  • Exercise restores your body's fat gauge: If you wanted to pointedly summarize the exercise induced reductions in leptin expression, the associated restoration of leptin sensitivity in the obese, and the increased adiponectin release relative to the increase in fat cell diameter, you could actually say that exercise restores your body's fat gauge. It allows your brain and the other organs to see how much body fat you still got and have them react appropriately. Funnily this is also why you body will, clever as is is, pull the emergency break, whenever your body fat levels become too low (cf. "The Athlete Triad Series").
Did you know that 10% of the fat cells have to be renewed every year? I know this is speculative and we are not talking about ZERO adipocyte maturation here, but what do you think will happen when a fat cell is due and you just hit the off-switch on adipocyte maturation?
A final word of caution: I am well aware that some of you may take this article as justification for training themselves into the ground. So please(!) keep in mind that hypoxia induced WNT10 and stretch induced WNT10b signaling, as well as most of the other fancy stuff you have learned about in the previous paragraphs are stress responses that require adequate recovery periods for the metabolic and growth responses they induce to take effect. Sleep, Eat, Train, Rest, Sleep, Eat, Train, Rest, Sleep, Eat... do you notice something? Yeah, right that's a 3/1 ratio of non-stressful occupations, namely sleeping, eating and resting to a single stressor, i.e. training. In other words, 25% of your result are "made" in the gym, 75% in bed (don't make it too stressful there ;-), in the kitchen and even, when you spend time with friends and family or simply sprawl out on the couch. Think of that, when you're designing your next training routine.

References:
  • Armstrong DD, Esser KA. Wnt/beta-catenin signaling activates growth-control genes during overload-induced skeletal muscle hypertrophy. Am J Physiol Cell Physiol. 2005 Oct;289(4):C853-9. Epub 2005 May 11.
  • Akimoto T, Ushida T, Miyaki S, Akaogi H, Tsuchiya K, Yan Z, Williams RS, Tateishi T. Mechanical stretch inhibits myoblast-to-adipocyte differentiation through Wnt signal-ing. Biochem Biophys Res Commun. 2005; 329: 381-385
  • Izawa T, Ogasawara J, Sakurai T, Nomura S, Kizaji T, Ohno H. Recent advances in the adaptations of adipose tissue to physical activity: Morphology and adipose tissue cellularity. J Phys Fitness Sports Med. 2013:1(3): 381-387. 
  • Leal ML, Lamas L, Aoki MS, Ugrinowitsch C, Ramos MS,  Tricoli V, Moriscot AS. Effect of different resistance-training regimens on the WNT-signaling pathway. Eur J Appl  Physiol. 2011; 111: 2535-2545
  • Miyazaki S, Izawa T, Ogasawara JE, Sakurai T, Nomura S, Kizaki T, Ohno H, Komabayashi T.  Effect of exercise training on adipocyte-size-dependent expression of leptin and adiponectin. Life Sci. 2010; 86: 691-698.
  • Lundby C, Gassmann M, Pilegaard H. Regular endurance training reduces the exercise induced HIF-1alpha and HIF-2alpha mRNA expression in human skeletal muscle in normoxic conditions. Eur J Appl Physiol. 2006 Mar;96(4):363-9. Epub 2005 Nov 12.
  • Polesskaya A, Seale P, Rudnicki MA. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell. 2003 Jun 27;113(7):841-52.
  • Ross R, Dagnone D, Jones PJ, Smith H, Paddags A, Hudson R, Janssen I. Reduction in obesity and related comor-bid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med. 2000; 133: 92-103.
  • Sakurai T, Endo S, Hatano D, Ogasawara J, Kizaki T, Oh-ishi S, Izawa T, Ishida H, Ohno H. Effects of exercise training on adipogenesis of stromal-vascular fraction cells in rat epididymal white adipose tissue. Acta Physiol (Oxf). 2010; 200: 325-338.
  • Stallknecht B. 2004. Influence of physical training on adipose tissue metabolism -- with special focus on effects of insulin and epinephrine. Dan Med Bull. 2004; 51: 1-33.
  • Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond). 2009 Jan;33(1):54-66.

Tuesday, January 22, 2013

Arginine a BAT Building WAT Killer & Repartitioning Agent? Plus: The Arginine Enriched Biscuits Diet ;-)

Whenever the word "vascularity" appears on one of the boards, this image pops up. Now we know that arginine alone won't make your veins pop, but could it be that we have hitherto overlooked that it could help you meet another more important criteria to look like that - namely to drop body fat?
In a 2013 paper Mohammad Alizadeh and his colleagues published a paper in the Annals of Nutrition & Metbabolism. The paper deals with the effects of the addition of 5g/day l-arginine to hypocaloric diets in a group of 84 premenopausal women, where the supplement regimen led to significantly greater reductions in visceral obesity (8cm vs. just 4cm reduction in waist circumference within 6 weeks; cf. Alizadeh. 2013). I filed the paper in my "candidates" folder and forgot about it - simply too much interesting news to cover everything.

Now, almost a year later, Lucilla D. Monti et al. have published yet another paper on l-arginine in the latest issue of the scientific journal Metabolism (Monti. 2013). "A pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome" as the title tells us and reason enough for me to take another look at an amino acid that has gotten sort of a bad rep as a supplemental non-starter, because the marketing machinery of the bodybuilding supplement producer has been pimping it as an "nitric oxide (NO) booster" (which is similar to saying that bricks were 'house builders' by the way).

Arginine cookies the saviors of the human race!?

Just so there is no misunderstanding here, while arginine may be more useful as a weight loss tool (esp. for the insulin resistant), it is neither an NO booster, nor a fat burner in the sense that it would "actively" do anything to elicit the named effects. The additional 4cm the arginine stripped off the waists of the initially mentioned ~28-44year-old women, for example, occurred in the context of a diet containing 500kcal less than the baseline diet (that's about -20% and the average subject ended up eating ~2000kcal/day).

Figure 1: As this illustration goes to show you, nitric oxide (NO) play and important role in the activation of PPAR-alpha and will thus determine (among other factors) if your immature fat cells become ugly passive and potentially health threatening stores or metabolically active brown adipose tissue (based on Wu. 2013).
Nevertheless, it is unquestionably interesting that Zhenlong Wu et al. remark in one of the more recent reviews on the fat loss effects of l-arginine that the inconspicuous nitric oxide precursor has the hardly known ability to
"increases mammalian BAT growth and development via mechanisms involving gene expression, nitric oxide signaling, and protein synthesis [, so that t]his enhances the oxidation of energy substrates and, thus, reduces white fat accretion in the body." (Wu. 2013)
Usually I would discard these effects as "most likely irrelevant for virtually BAT free mammals" like humans (even those among us with a "high" amount of brown adipose tissue have way less of it than the average "mammal" does; this is particularly true if you compare us to our small hairy mammalian brethren that are living in lab cages ;-).

With the positive effects that have already been observed in past human studies and the "growth promoting effect" arginine is supposed to have on mammalian brown adipose tissue (cf. figure 1), the potential weight loss and ensuing health benefits of the "conditionally essential" (meaning you must consume it in significant amounts under certain circumstances, like bein very sick, burned, hurt, etc. though your body can theoretically produce it on its own) amino acid appear to be well-worth being mentioned in a SuppVersity article again (again, because I already mentioned these effects as an aside in Part II of the Amino Acids for Super Humans Series back in 2011.

Back to the cookies then

After this lengthy general introduction, let's now finally have a look at the Monti study (Monti. 2013). Now, despite the auspicious term "pilot study" in the title of the Italian researcher latest paper, the idea to add some l-arginine to cookies, biscuits and other stuff is actually not really new. In 2011, already, he same research group has published a paper on this concept with initial data on the acute response to the ingestion of arginine enriched biscuits (see previous SuppVersity post). So, the "pilot trial" is actually nothing but a slightly revamped version of the initial test in 7 healthy subjects, plus a 2-week extension in which the scientists probed the effects of the chronic ingestion of their biscuits on 15 obese subjects (8 men, 7 women, aged 62.5±3.5years; BMI ~30kg/m²; 36% body fat) with impaired glucose tolerance (IGT) and metabolic syndrome (MS).
Figure 2: Weight loss, fat loss and insulin sensitivity (*I divided the actual values on the Matsuda index by 10 so that they would fit into the same graph), as well as glucose response during an OGGT (Monti. 2013)
While the results of the former trial were very similar to those in the pilot of the pilot study (see previous SuppVersity post), the data in figure 1 goes to show you that the "long-term" (14-days, with a wash out period of another 14 days and a cross-over afterwards, so that every subject was tested both for the effects of the placebo and the acuve treatment), were promising and statistically significant, but far from representing a solution to the diabesity epidemic.

During each of the two 14-day intervention periods, the obese volunteers had consumed identically packaged L-arginine-enriched biscuits containing 6.6g l-arginine, 21.9g carbohydrates (15g available
carbohydrates and 6.9g resistant starch), 3.6g protein, 7.5g fat or an isoenergetic biscuit without the 6.6g of l-arginine as morning and afternoon snack . The additional 171kcal provided by the biscuits were included in the daily allowance of the subjects who followed a 55% carbohydrate, 25%–30% fat and 15%–20% protein diet that contained a total of 1,600kcal during the whole 6-week study period (the study used a randomized cross over design with a 2-week washout in-between).

Let's get back to a more general perspective

Not just because I'd hope that most of you don't have just as much weight to lose as the participants of the Monti study, but also in view of statements like "[a]nother added value of the biscuit is the low protein content (6.1% vs. 20%–50%)" (Monti. 2013) in the discussion of the paper, I don't want to go into more details on this particular study, but rather return to a more general analysis of the metabolic effects of l-arginine in these last paragraphs. I mean, it should be obvious that the important most important question here is: "Is there any metabolic benefit of arginine supplementation, or not?

The results of the Monti study clearly show that there is (and that despite the fact that its authors' don't appear to have a grasp of the latest research results). Monti's paper does yet not describe the only experiment, the results of which would suggest that there is more to arginine than nitric oxide - or, if we go by the overview in figure 1, that there is more to nitric oxide than the pump.
  • In June 2013, researchers from the Poznan University of Medical Sciences in Poland, for example, published a paper in which they report that the provision of 9g/day of the nitric oxide precursor l-arginine for 3-months lead to statistically highly significant improvements in insulin sensitivity and a non-significant 1% reduction in body fat in the absence of any changes in dietary or activity patterns in patients with visceral obesity (BMI 39kg/m²). It did yet not, as the scientists had speculated reduce the expression of tumor necrosis factor alpha (TNF-alpha), so that we have to assume that the beneficial effects on glucose management were not mediated by any hitherto largely ignored direct anti-inflammatory effects of the amino acid the Swiss chemist Ernst Schultze discovered in 1886 (Bogdanski. 2013). 
  • In the American Journal of Physiology. Endocrinology and Metabolism Lucotti et al. reported in 2006 that the addition of l-arginine (8.3g/day) to a combined diet plus exercise program for 21 days had highly beneficial effects on the study outcome, promoted the loss in fat mass (3kg vs. 2kg) and waist circumference (10cm vs. 3cm; no typo!), helped preserve lean mass (0kg vs. 2kg muscle loss) and improved the mean daily glucose profiles and the amount of fructosamine, a glycated serum protein and marker of poor glucose control, in the blood (Lucotti. 2006). Moreover, the supplementaion protocol increased the nitric oxide production, the andioxidant capacity and the adiponectin levels and improved the adiponectin-to-leptin ratio of the 25 women and 8 men (all obese, BMI ~39kg/m²) who participated in the study. 
  • In addition, studies on rodents and pigs have conclusively shown that arginine supplementation can increase the use and decrease the storage of fatty acids in different dietary scenarios (Fu. 2005; Jobgen. 2009; Tan. 2011).
One thing we should not forget, though is that there may in fact be something like an "arginine timing" effect, which could play a role in it's effect on body composition. In the scientific journal Amino Acids Smajilovic et al. report only recently that the l-arginine induced release of insulin is not mediated by a direct interaction of the alpha-amino acid with the amino acid receptors on the pancreas. Now, despite the fact that we do not know how, the mere fact that arginine will produce an immediate release of insulin tells us that it's use before / with a meal, would be more beneficial than during periods of fasting. This is particularly true for people who are either developing or at risk of developing insulin resistance and type II diabetes. After all, the decline in the early insulin response to the meal has been implicated as one of the first and most important steps in the etiology of type II diabetes (Pratley. 2001; Del Prato. 2002).

Is timing crucial and what about the arginine induced insulin release?

Maybe it's even it's effect on the health of your intestines (read more about that) that helps weight loss, who knows?
Unfortunately, few studies report whether the arginine was ingested before or with a meal. What we do know from the Monti study, however,  is that it's presence in the meal (which would be equal to the co-ingestion of supplemental l-arginine) tripled the amount of body fat the dieting subjects lost in the course of the two week intervention (2.02kg vs. 0.70kg). In conjunction with the previously mentioned ability to boos pancreatic insulin production, this observation would invalidate the still widely heralded assumption that a robust, appropriate early insulin response (critics would call it a "spike") would be something to be avoided at all costs - if it were, the l-arginine should have decreased the efficacy of the diet, right?

What we should however keep in mind, though is that a robust initial insulin response will lead to a faster reduction of blood glucose in into the normal range. That it turn will (ideally) render the release of even more insulin obsolete so that the initial spike will actually allow you to avoid the far more detrimental chronically (or in a "healthy" individual "long-term") elevation of insulin and can thus have the bring about the exact opposite of what most people believe it will do: weight loss, or a reduction in weight gain!

"So does it work and if so how? Can't be insulin, alone, can it?"

It is nevertheless unlikely that the increased acute response of the pancreas is the only mechanism (I would bet probably not even the most important one) by which increases in the amount of arginine in the diet facilitate and as examples like the study by Bogdanski et al. (Bogdanski. 2013) even trigger weight loss (remember: the obese subjects in this study did not do anything but take 9g/day of supplemental l-arginine three times a day).

Effects by which arginine could promote fat loss and body recompositioning: Stimulation of lypolysis (release fat from adipose tissue); activation of genes that are responsible for the oxidation of fatty acids; interaction with PGC-1 alpha and triggers mitochondrial biogenesis and the "browning" of fat; regulation of adipocyte-muscle crosstalk resulting in an energy repartitioning effect away from the adipose and towards the muscle tissue; activation of the AMPK pathway, resulting in improvements in both lipid and glucose metabolism.
According to a review by Tan et al., both the additive (dieting + arginine = better fat loss), as well as the "stand alone" (simply adding arginine on top of whatever diet you are following) effects of the nitric oxide precursor could be brought about by a combination of various factors (Tan. 2013). We have already seen in figure one that the nitric oxide exerts direct agonistic effects on PPAR-alpha. We also know that other substances such as fish oil and TTA (see "TTA + Fish Oil - Fat Burning Super Fats?"), which are likewise PPAR-alpha agonists will also promote the oxidation of fatty acids (specifically in the liver). Now, if you add the list of metabolic benefits, the scientists from the Institute of Subtropical Agriculture at the Chinese Academy of Sciences in Changsha and their colleagues from the Texas A&M University have compiled (see infobox on the right), you will have to concede that your pre-workout nitric oxide booster would - at least on paper - make a pretty decent "fat burner", if all these effects, most of which have been observed in either rodents or pigs could be replicated in human beings.

Bottom line: For the metabolically deranged, the evidence is there. For followers of physical culture, on the other hand, there is as of yet no clear cut proof for the fat burning or repartitioning effects of l-arginine. Ah, and just in case you consider your little N=1 experiment with whatever pre-workout supplement evidence that it does not work - forget about that. With the minuscule amounts of l-arginine most of these products contain you can hardly make a difference when your basal diet does deliver tons of arginine, already (plus: you were probably taking it at the wrong time, namely on empty before a workout).

So do I suggest you buy a 5kg pouch of bulk l-arginine and go through it within 2 weeks? No, certainly not. You better wait until more data becomes available. For now, it would suffice if you don't fall for the anti-hype that's at least in part instigated by the same supplement companies that have been pimping l-arginine a couple of years ago as the ueber-supplement and an absolute must have for any serious trainee. I mean if you had the choice between six pack abs lasting 24/7 and a pump, what would you pick? I thought so... therefore this new area of application, could turn out to be way more exciting than the never-established, but highly marketed NO-boosting effects of l-arginine.

    References:
    • Alizadeh M, Safaeiyan A, Ostadrahimi A, Estakhri R, Daneghian S, Ghaffari A, Gargari BP. Effect of L-arginine and selenium added to a hypocaloric diet enriched with legumes on cardiovascular disease risk factors in women with central obesity: a randomized, double-blind, placebo-controlled trial. Ann Nutr Metab. 2013;60(2):157-68.
    • Bogdanski P, Suliburska J, Grabanska K, Musialik K, Cieslewicz A, Skoluda A, Jablecka A. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity. Eur Rev Med Pharmacol Sci. 2013 Jun;16(6):816-23.
    • Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes. 2002 Feb;51 Suppl 1:S109-16.
    • Fu WJ, Haynes TE, Kohli R, Hu J, Shi W, Spencer TE, Carroll RJ, Meininger CJ, Wu G. Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr. 2005 Apr;135(4):714-21.
    • Jobgen W, Fu WJ, Gao H, Li P, Meininger CJ, Smith SB, Spencer TE, Wu G. High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids. 2009 May;37(1):187-98.
    • Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E906-12.
    • Monti LD, Casiraghi MC, Setola E, Galluccio E, Pagani MA, Quaglia L, Bosi E, Piatti P. l-Arginine enriched biscuits improve endothelial function and glucose metabolism: A pilot study in healthy subjects and a cross-over study in subjects with impaired glucose tolerance and metabolic syndrome. Metabolism. 2013; 62:255–26.
    • Pratley RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia. 2001 Aug;44(8):929-45.
    • Tan B, Yin Y, Liu Z, Tang W, Xu H, Kong X, Li X, Yao K, Gu W, Smith SB, Wu G. Dietary L-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle. J Nutr Biochem. 2011 May;22(5):441-5.
    • Tan B, Li X, Yin Y, Wu Z, Liu C, Tekwe CD, Wu G. Regulatory roles for L-arginine in reducing white adipose tissue. Front Biosci. 2013 Jun 1;17:2237-46.